National Institute of Biomedical Imaging and Bioengineering; Notice of Meeting, 75263 [06-9708]
Download as PDF
<![CDATA[
Federal Register / Vol. 71, No. 240 / Thursday, December 14, 2006 / Notices
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Alcohol Abuse and Alcoholism Initial
Review Group, Clinical and Treatment
Subcommittee.
Date: March 1–2, 2007.
Time: 8:30 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Double Tree Rockville, 1750
Rockville Pike, Rockville, MD 20852.
Contact Person: Katrina L. Foster, PhD.,
Scientific Review Administrator, National
Institute on Alcohol Abuse & Alcoholism,
National Institutes of Health, 5635 Fishers
Lane, Rm. 3042, Rockville, MD 20852, 301–
443–4032. katrina@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.271, Alcohol Research
Career Development Awards for Scientists
and Clinicians; 93.272, Alcohol National
Research Service Awards for Research
Training; 93.273, Alcohol Research Programs;
93.891, Alcohol Research Center Grants,
National Institutes of Health, HHS)
Dated: December 7, 2006.
Anna Snouffer,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 06–9707 Filed 12–13–06; 8:45 am]
BILLING CODE 4140–01–M
National Institutes of Health
rwilkins on PROD1PC63 with NOTICES
National Institute of Biomedical
Imaging and Bioengineering; Notice of
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of a meeting of the
National Advisory council for
Biomedical Imaging and Bioengineering.
The meeting will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the contact Person listed below in
advance of the meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
17:54 Dec 13, 2006
Jkt 211000
Name of Committee: National Advisory
Council for Biomedical Imaging and
Bioengineering, January 26, 2007 Council
Meeting.
Date: January 26, 2007.
Open: 8:45 a.m. to 12:15 p.m.
Agenda: Report from the Institute Director,
other Institute Staff and presentations of
working group reports.
Place: Bethesda Marriott Suites, 6711
Democracy Boulevard, Bethesda, MD 20817.
Closed: 1:15 p.m. to 3:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: Bethesda Marriott Suite, 6711
Democracy Boulevard, Bethesda, MD 20817.
Contact Person: Anthony Demsey, PhD,
Director, Office of Extramural Policy,
National Institute of Biomedical Imaging and
Bioengineering, 6701 Democracy Blvd.,
Room 241, Bethesda, MD 20892.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business of professional
affiliation of the interested person.
Information is also available on the
Institute’s/Center’s home page: https://
www.nibib1.nih.gov/about/NACBIB/
NACBIB.htm, where an agenda and any
additional information for the meeting will
be posted when available.
Dated: December 7, 2006.
Anna Snouffer,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 06–9708 Filed 12–13–06; 8:45 am]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
VerDate Aug<31>2005
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Drug Abuse;
Notice of Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The contract proposals and
the discussions could disclose
confidential trade secrets or commercial
PO 00000
Frm 00037
Fmt 4703
Sfmt 4703
75263
property such as patentable material,
and personal information concerning
individuals associated with the contract
proposals, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel, State
and Local Epidemiology Planning and
Information Development.
Date: January 24–25, 2007.
Time: 9 a.m. to 5 p.m.
Agenda: To review and evaluate contract
proposals.
Place: Courtyard by Marriott Rockville,
2500 Research Boulevard, Rockville, MD
20850.
Contact Person: Lyle Furr, Contract Review
Specialist, Office of Extramural Affairs,
National Institute on Drug Abuse, NIH,
DHHS, Room 220, MSC 8401, 6101 Executive
Boulevard, Bethesda, MD 20892–8401, (301)
435–1439, lf33c.nih.gov.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel,
Development of Science Literacy Materials or
Programs.
Date: February 7, 2007.
Time: 9 a.m. to 6 p.m.
Agenda: To review and evaluate contract
proposals.
Place: Courtyard by Marriott Rockville,
2500 Research Boulevard, Rockville, MD
20850.
Contact Person: Lyle Furr, Contract Review
Specialist, Office of Extramural Affairs,
National Institute on Drug Abuse, NIH,
DHHS, Room 220, MSC 8401, 6101 Executive
Boulevard, Bethesda, MD 20892–8401, (301)
435–1439, lf33c.nih.gov.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel,
Mechanisms and Methods to Maximize Data
Utilization.
Date: February 21, 2007.
Time: 9 a.m. to 6 p.m.
Agenda: To review and evaluate contract
proposals.
Place: Courtyard by Marriott Rockville,
2500 Research Boulevard, Rockville, MD
20850.
Contact Person: Lyle Furr, Contract Review
Specialist, Office of Extramural Affairs,
National Institute on Drug Abuse, NIH,
DHHS, Room 220, MSC 8401, 6101 Executive
Boulevard, Bethesda, MD 20892–8401, (301)
435–1439, if33c.nih.gov.
Name of Committee: National Institue on
Drug Abuse Special Emphasis Panel,
Development of Practical Training Materials
for Evidence-Based Treatment.
Date: March 13, 2007.
Time: 9 a.m. to 6 p.m.
Agenda: To review and evaluate contract
proposals.
Place: Courtyard by Marriott Rockville,
2500 Research Boulevard, Rockville, MD
20850.
Contact Person: Lyle Furr, Contract Review
Specialist, Office of Extramural Affairs,
National Institute on Drug Abuse, NIH,
DHHS, Room 220, MSC 8401, 6101 Executive
Boulevard, Bethesda, MD 20892–8401, (301)
435–1439, if33c.nih.gov.
E:\FR\FM\14DEN1.SGM
14DEN1
]]>Agencies
[Federal Register Volume 71, Number 240 (Thursday, December 14, 2006)]
[Notices]
[Page 75263]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 06-9708]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Biomedical Imaging and Bioengineering;
Notice of Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of a meeting of
the National Advisory council for Biomedical Imaging and
Bioengineering.
The meeting will be open to the public as indicated below, with
attendance limited to space available. Individuals who plan to attend
and need special assistance, such as sign language interpretation or
other reasonable accommodations, should notify the contact Person
listed below in advance of the meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Advisory Council for Biomedical
Imaging and Bioengineering, January 26, 2007 Council Meeting.
Date: January 26, 2007.
Open: 8:45 a.m. to 12:15 p.m.
Agenda: Report from the Institute Director, other Institute
Staff and presentations of working group reports.
Place: Bethesda Marriott Suites, 6711 Democracy Boulevard,
Bethesda, MD 20817.
Closed: 1:15 p.m. to 3:30 p.m.
Agenda: To review and evaluate grant applications.
Place: Bethesda Marriott Suite, 6711 Democracy Boulevard,
Bethesda, MD 20817.
Contact Person: Anthony Demsey, PhD, Director, Office of
Extramural Policy, National Institute of Biomedical Imaging and
Bioengineering, 6701 Democracy Blvd., Room 241, Bethesda, MD 20892.
Any interested person may file written comments with the
committee by forwarding the statement to the Contact Person listed
on this notice. The statement should include the name, address,
telephone number and when applicable, the business of professional
affiliation of the interested person.
Information is also available on the Institute's/Center's home
page: https://www.nibib1.nih.gov/about/NACBIB/NACBIB.htm, where an
agenda and any additional information for the meeting will be posted
when available.
Dated: December 7, 2006.
Anna Snouffer,
Acting Director, Office of Federal Advisory Committee Policy.
[FR Doc. 06-9708 Filed 12-13-06; 8:45 am]
BILLING CODE 4140-01-M
